Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone—Translational Aspects and Clinical Perspectives across Multiple Organ Systems

por Kolkhof, Peter, Lawatscheck, Robert, Filippatos, Gerasimos, Bakris, George L.
Publicado 2022

Does Telemedical Support of First Responders Improve Guideline Adherence in an Offshore Emergency Scenario? A Simulator-Based Prospective Study

por Landgraf, Philipp, Spies, Claudia, Lawatscheck, Robert, Luz, Maria, Wernecke, Klaus-Dieter, Schröder, Torsten
Publicado 2019

Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY...

por Pitt, Bertram, Agarwal, Rajiv, Anker, Stefan D., Ruilope, Luis M., Rossing, Peter, Ahlers, Christiane, Brinker, Meike, Joseph, Amer, Lambelet, Marc, Lawatscheck, Robert, Filippatos, Gerasimos S.
Publicado 2022

Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon‐like peptide‐1 receptor agonist use

por Rossing, Peter, Agarwal, Rajiv, Anker, Stefan D., Filippatos, Gerasimos, Pitt, Bertram, Ruilope, Luis M., Fonseca, Vivian, Umpierrez, Guillermo E., Caramori, Maria Luiza, Joseph, Amer, Lambelet, Marc, Lawatscheck, Robert, Bakris, George L.
Publicado 2022

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone

por Agarwal, Rajiv, Pitt, Bertram, Rossing, Peter, Anker, Stefan D., Filippatos, Gerasimos, Ruilope, Luis M., Kovesdy, Csaba P., Tuttle, Katherine, Vaduganathan, Muthiah, Wanner, Christoph, Bansilal, Sameer, Gebel, Martin, Joseph, Amer, Lawatscheck, Robert, Bakris, George L.
Publicado 2023

Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

por Flack, John M., Agarwal, Rajiv, Anker, Stefan D., Pitt, Bertram, Ruilope, Luis M., Rossing, Peter, Adler, Sharon G., Fried, Linda, Jamerson, Kenneth, Toto, Robert, Brinker, Meike, Farjat, Alfredo E., Kolkhof, Peter, Lawatscheck, Robert, Joseph, Amer, Bakris, George L.
Publicado 2023

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

por Agarwal, Rajiv, Pitt, Bertram, Palmer, Biff F, Kovesdy, Csaba P, Burgess, Ellen, Filippatos, Gerasimos, Małyszko, Jolanta, Ruilope, Luis M, Rossignol, Patrick, Rossing, Peter, Pecoits-Filho, Roberto, Anker, Stefan D, Joseph, Amer, Lawatscheck, Robert, Wilson, Daniel, Gebel, Martin, Bakris, George L
Publicado 2022

Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

por Rosas, Sylvia E., Ruilope, Luis M., Anker, Stefan D., Pitt, Bertram, Rossing, Peter, Bonfanti, Andres Angelo Cadena, Correa-Rotter, Ricardo, González, Fernando, Munoz, Carlos Francisco Jaramillo, Pergola, Pablo, Umpierrez, Guillermo E., Scalise, Andrea, Scott, Charlie, Lawatscheck, Robert, Joseph, Amer, Bakris, George L.
Publicado 2023